Dale Sanders

Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom.

Inspiralis Ltd. supplies topoisimerase products and services to the pharmaceutical industry. Its services include topoisomerase inhibitor screening services, medium/high throughput topoisomerase assay, investigation of protein-DNA interactions with ReDCaT chip, cloning, expression and assay services. The company was founded by Anthony Maxwell, Nicolas P. Burton and Nicolas P. Burton in 1995 and is headquartered in Norwich, the United Kingdom.

Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Quadram Institute Bioscience operates as a non-profit organization that provides food research for health and prevention of food related diseases. The organization serves science research base, industry, clinical practice via health and preventive medicine and evidence-based policy for government and industry. The company was founded in November 1986 and is headquartered in Norwich, the United Kingdom.

Longas Technologies Pty Ltd. is engaged in developing next generation sequencing (NGS) technologies. The company was founded by Ian Charles, Aaron Darling, and Catherine Burke in 2015 and is headquartered in Sydney, Australia.

New Anglia Local Enterprise Partnership Ltd. works with businesses and local authority partners to help grow jobs and increase productivity. The company was founded in 2010 and is headquartered in Norwich, the United Kingdom.

Part of Süddeutsche Zuckerrübenverwertungs-Genossenschaft eG, Aquifer Ltd. is a holding company. The company is based in Leatherhead, UK.

East African Tea Investments provides investment and business support services. The non-profit company is based in Aberdeen, UK and was founded in 2012.

The Big C Appeal Ltd. is a cancer charity that provides support to anyone affected by cancer, from diagnosis and treatment to life beyond cancer. The charity is proud to be a part of the innovative Norwich Research Park, with their head office located alongside the research institutes they fund. The non-profit company is based in Norwich, UK, and the CEO is Christopher Bushby. The British company offers research grant applications, a research advisory panel, and a peer review process to ensure excellent research governance. The company works closely with NNUH, James Paget University Hospital, and The Queen Elizabeth Hospital. Big C was founded in 1980 by David Moar and Clive Bamford, and it is the largest cancer charity in the area.

Babraham Bioscience Technologies Ltd. provides business research and consulting services. It also offers financial and administrative services to start-up biotech companies. The company was founded in 1996 and is located in Cambridge, UK

PBL-Ventures is the business start-up and mentoring arm of Plant Bioscience Ltd founded in 1994. The firm is headquartered in the UK.

Norfolk & Norwich University Hospital engages in the provision of health care services. It offers cancer care and radiotherapy, orthopaedics, plastic surgery, ophthalmology, rheumatology, children’s medicine and surgery, and specialist care for sick and premature babies. The company is headquartered in Norwich, the United Kingdom.

Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom.

Imperial College Healthcare NHS Trust is a non-profit organization which provides community and healthcare services. It offers cardiology, endocrinology, melanoma, maternity ultrasound, maternal medicine, and major trauma center. The organization was founded on October 1, 2007 and is headquartered in London, the United Kingdom.

Chiltern International Group Ltd. operates as a holding company with interests in providing clinical development and other outsourced services to the pharmaceutical, medical device and biotechnology industries. The company was founded on May 23, 2006 and is headquartered in Edinburgh, the United Kingdom.

Agency For Science Technology & Research Ventures is a Venture Capital firm, a subsidiary of Agency for Science, Technology & Research founded in 1991 with headquartered in Singapore.

Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore.

Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom.

Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom.

Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million.

Part of BenevolentAI SA, BenevolentAI Bio Ltd. is a clinical-stage AI-enabled drug discovery and British development company founded in 2013. The company is based in London, UK. BenevolentAI Bio uses AI to augment scientific ingenuity in the drug discovery process, from target identification to clinical development, with the goal of improving the probability of clinical success. The company has refined and formalized its approach to sustainability under the direction of the newly established environmental, social, and governance (ESG) governance structure and teams. BenevolentAI Bio's AI-enabled Benevolent Platform™ empowers scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug.

Chiltern International, Inc. provides clinical research services. It offers clinical development, medical and scientific affairs, data and analysis, pharmacovigilance and strategic regulatory services. The firm serves biotech, pharmaceuticals, biosimilars and biologics and medical device and diagnostics industries. The company was founded in 1982 and is headquartered in Slough, the United Kingdom.